Outcomes in antiretroviral-naive HIV-infected patients initiating therapy with TDF/FTC plus either atazanavir/r or another third recommended drug

por Billaud, E, Lacombe, JM, Abgrall, A, Ghosn, J, Launay, O, Livrozet, JM, Meynard, JL, Pavie, J, Costagliola, D
Publicado 2010